Dermatology
| Atopic Dermatitis
Dermatology
Atopic Dermatitis

Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review

book_2 Source: J Eur Acad Dermatol Venereol. 2022 Jun;36(6):820-835. 
calendar_today Published on Medfyle: October 2022
import_contacts 7 min
headphones 4 min

In this medfyle

Systematic review of current scientific evidence of DIOSD in AD, which investigates the possible interlinking pathological mechanisms between the two conditions and management options.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Expert commentary

Giampiero Girolomoni, MD

University of Verona School of Medicine
Verona, Italy

About this Medfyle
Read more arrow_downward Hide arrow_upward

This Medfyle is provided as a service to healthcare professionals. It is a summary of an article originally published in the Journal of the European Academy of Dermatology and Venereology.
The summary was prepared by Marta Castano on behalf of Medfyle and reviewed by Giampiero Girolomoni, MD.

Original article:
Neagu N, Dianzani C, Avallone G, Dell'Aquila C, Morariu SH, Zalaudek I, Conforti C. Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):820-835. doi: 10.1111/jdv.17981. Epub 2022 Feb 17. PMID: 35122335.

The authors of the original article, the publisher, and the EADV were not involved in the creation of the summary.


Feedback